Idiopathic pulmonary fibrosis (IPF) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051122

This document outlines details of PBS-subsidised nintedanib and pirfenidone for patients with idiopathic pulmonary fibrosis (IPF).

For details on how to process a PBS Authority, see Processing Complex Authority Required Listings.

Restrictions	Authority level and section	PA assessment	Processing system	Prescriber type	Prescriber self-serve
Initial PB208 form	Written Electronic S85: nintedanib pirfenidone	No	OPA	Must be treated by, or in consultation with a: respiratory physician specialist physician	Yes
Change/Recommencement	Telephone Electronic S85: nintedanib pirfenidone	No	OPA	Must be treated by, or in consultation with a: respiratory physician specialist physician	Yes
Continuing	Telephone Electronic S85: nintedanib pirfenidone	No	OPA	Must be treated by, or in consultation with a: respiratory physician specialist physician	Yes

Operational Information